IL17A and rheumatoid arthritis: However, miR-23a was found to be decreased in arthritis chondrocytes during rheumatoid arthritis pathogenesis and psoriatic arthritis, and miR-23a expression directly targeted inhibitor of kappa B kinase α (IKKα) to inhibit IL-17-mediated pro-inflammatory mediator expression (41, 42).